REVIEW
|
doi:10.20944/preprints202206.0160.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
breast cancer; HER2-positive; estrogen receptor positive; triple-positive; HER2-targeted therapy; immunotherapy
Online: 10 June 2022 (11:03:05 CEST)